Arkolith/Insider Trading/CERO/Form 4/A

Atwood Brian G

Chief Executive Officer, DirectorCERO THERAPEUTICS HOLDINGS, INC. (CERO) · full profile →Form 4/A · filed Mar 11, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 14, 2024Other(J)101K——101K
Feb 14, 2024Other(J)148K——249K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 14, 2024Grant(A)14K—$014K
Feb 14, 2024Grant(A)1K$1000.00$1.0M1K

Transaction Codes

J
Other acquisition / disposition
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001213900-24-021525) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML